CPL Aromas Limited – Trademark Portfolio

Entity Type: 99

CPL Aromas Limited holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 5 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 5 Nice Classification classes.

Scaldwell Industrial Estate,

Quarry Road, Brixworth NORTHAMPTON NN6 9UB

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

CPL Aromas Limited's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

3
Cosmetics & Cleaning (5 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (3 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

42
Computer & Scientific (3 filings)

Scientific and technological services; industrial analysis and research services

40
Treatment & Processing (2 filings)

Treatment of materials

Frequently Asked Questions

How many trademarks does CPL Aromas Limited have?

CPL Aromas Limited has 7 U.S. trademarks filed with the USPTO.

What trademark classes does CPL Aromas Limited file in?

CPL Aromas Limited files trademarks across 5 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 40 (Treatment & Processing). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.

What is CPL Aromas Limited's trademark registration success rate?

CPL Aromas Limited has a 0% trademark registration rate, with 0 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.